CompletedNot Applicable

Efficacy of the Pelvic Clock® Device for Functional Recovery After Robotic-Assisted Radical Prostatectomy

Taiwan60 participantsStarted 2024-10-01

Plain-language summary

This randomized controlled trial evaluates the efficacy of the Pelvic Clock® device, a proprioceptive neuromuscular facilitation tool, in accelerating functional recovery following Robotic-Assisted Radical Prostatectomy (RARP). The study compares the device intervention against standard Pelvic Floor Muscle Training (PFMT) instructions. The primary goal is to assess the "Trifecta" achievement rate (cancer control, urinary continence, and potency) at 6 months post-surgery.

Who can participate

Age range55 Years – 80 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with localized prostate cancer. * Scheduled for Robotic-Assisted Radical Prostatectomy (RARP). * Age between 55 and 80 years. Exclusion Criteria: * History of neurological disorders affecting pelvic floor function (e.g., -Parkinson's disease, multiple sclerosis, CVA). * Adjuvant radiotherapy or androgen deprivation therapy. * Salvage prostatectomy. * Advanced tumor stage (cT4 or N+). * Prior pelvic surgery or radiation. * Cognitive impairment or physical inability to perform prescribed exercises .

What they're measuring

Trifecta Achievement Rate

Timeframe: 6 months post-surgery

Trial details

NCT IDNCT07333807

SponsorTri-Service General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-31

View on ClinicalTrials.gov More Prostate Cancer trials